BioCentury
ARTICLE | Company News

Novo Nordisk, Schering deal

September 30, 1996 7:00 AM UTC

The companies will collaborate to develop drugs for contraception and to treat infertility, focusing on compounds that modulate the biosynthesis of natural meiosis-activating sterols (MAS), present in...